PatientPoint has just announced that it has combined with Outcome Health to create PatientPoint Health Technologies — a new platform company offering tech-enabled patient engagement solutions that create more effective doctor-patient interactions across the entire patient care journey.
The combined company will help meet the tech-enabled patient engagement needs of nearly 150,000 unique healthcare providers and impact roughly 750 million patient visits each year.
PatientPoint Founder and CEO Mike Collette told us “This timely, strategic transaction both underscores our commitment to growth, and to offering our high-value, tech-enabled patient engagement solutions to as many providers as possible to help them meet the demands of a rapidly evolving healthcare industry. “By leveraging the best talent and technology from both PatientPoint and Outcome Health, we will be well positioned to expand our suite of innovative patient engagement solutions to deliver improved patient outcomes and a more personalized, relevant patient experience as well as enhanced scale and efficiency for our healthcare sponsors.”
PatientPoint Health Technologies will be led by PatientPoint’s current leadership team including Mike Collette as CEO, Linda Ruschau as Chief Client Officer, Pat O’Brien as Chief Financial Officer and Chris Martini as Chief Provider Officer. PatientPoint’s engineering and information technology teams will also be augmented by Outcome Health tech executives Glenn Keighley and Sean Barden.
Outcome Health’s CEO Matt McNally and COO Nandini Ramani are out.
The new platform company plans to leverage a combination of organic growth and M&A to continue to grow its provider base and to expand the suite of innovative, tech-enabled patient engagement solutions it can offer to its provider customers.
The combined entity will be majority owned by a group of investors including funds managed by L Catterton and Littlejohn & Co., LLC.
The new company will operate under the PatientPoint brand. Terms of the transaction were not disclosed.